Back to BlackRock, Inc. BlackRock, Inc.

ANVSANVS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ANNOVIS BIO INC

Yes. BlackRock holds 249,856 shares of ANVS (Annovis Bio), worth $464,732, as of its Q2 2026 13F filing. It increased the position by 110,323 shares (+79.1%) from Q1 2026. BlackRock has held ANVS in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$464,732

Current Shares

249,856

Total Value Change

-$353,319

Total Shares Change

+148,361

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
249,856
+79.1%
$464,7320.0%$1.86
25
2026-Q1
Unchanged
139,533
0.0%
$311,1590.0%$2.58
0
2025-Q4
Increased
139,533
+73.0%
$482,7840.0%$3.46
25
2025-Q3
Unchanged
80,675
0.0%
$166,9970.0%$2.04
0
2025-Q2
Decreased
80,675
-19.8%
$175,0650.0%$2.05
0
2025-Q1
Decreased
100,629
-10.1%
$150,9440.0%$1.65
0
2024-Q4
Increased
111,979
+10.3%
$563,2540.0%$5.08
18
2024-Q3
First report
101,495
-
$818,0510.0%$8.10
0

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used